Cellertz Bio has exciting news to share as the company recently secured $250,000 in funding to propel its innovative journey in cell therapy research and development. This significant investment reinforces the company’s commitment to harnessing the power of both in silico and experimental approaches to engineer next-generation cell therapies. By precisely controlling gene regulatory networks that define cell behaviors, Cellertz Bio is setting new benchmarks in the fight against cancer and other challenging diseases. This funding will be strategically allocated to advance the company’s groundbreaking research agenda, which focuses on determining the critical genes to control in order to achieve optimal therapeutic outcomes. With this infusion of capital, Cellertz Bio is positioned to enhance its capabilities in computational biology and experimental validation, bolstering efforts to streamline the design and testing of targeted therapies that are both effective and safe. The financial boost enables the company to invest in state-of-the-art technology, expand research teams, and collaborate with leading experts in genomics and biotechnology. As a pioneer in integrating cutting-edge computational models with laboratory experiments, Cellertz Bio is committed to transforming theoretical insights into tangible, life-saving therapies. The investment not only reflects strong confidence in the company’s scientific vision but also signals a crucial step forward in making advanced precision treatments accessible to patients worldwide. By determining which genes can be modulated to deliver robust therapeutic responses, Cellertz Bio is poised to drive a new era of personalized medicine, offering renewed hope to countless individuals battling severe illnesses.
Cellertz Bio Raises $250K to Drive Precision Gene-Controlled Cell Therapy Innovation
Get the full Cellertz Bio company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
LiveEO
LiveEO is a leading provider of Earth Observation technologies and solutions that revolutionize asset monitoring and enhance global supply chain transparency. Its cutting-edge AI and satellite analytics unlock the full potential of space data to deliver actionable insights, driving safety, efficiency, and sustainability across industries. Infrastructure operators rely on LiveEO to detect and prevent risks that could cause outages or disruptions, making their networks more resilient to climate change. Meanwhile, supply chain leaders use TradeAware, LiveEO’s EUDR compliance platform, to monitor deforestation risks, ensure regulatory alignment, and protect market access. With an international team of 130 people, LiveEO is dedicated to protecting life on Earth and accelerating the transition toward sustainable infrastructure and trade.
$7.7M Grant
today
startupmag.co.uk
Startupmag is a UK media platform reporting daily on the startup ecosystem, with funding news, founder interviews and data-led market insights. We publish every UK startup funding round each day, and maintain one of the country's most comprehensive datasets of investors, founders and funded startups. Our coverage powers the Startupmag Investor Database, tracking more than 7,000 investors across stages, sectors and regions. We map the full UK ecosystem to help founders, analysts, and operators understand who’s building, who’s backing, and where capital is flowing.
$550.0K Pre-seed
today
Calibre Technologies
CALIBRE TECHNOLOGIES, Based in Navi Mumbai with its additional business place at Mumbai, was founded in 1997 to provide a One-Stop Advanced Solution for all IT impediments. The main goal of the company is to “make technology reach the user at an affordable price and in the usable form”. As a Software Product and Solutions Company with vast expertise in advanced technologies, the company provides consultancy and develops High-Quality Customized software for End Users and for other IT Companies.
$3.0M Pre-seed
today
Capchase
Capchase is the modern vendor financing platform built for B2B software, cloud, and hardware companies. Our solution helps businesses offer flexible payment terms to their customers while getting paid upfront on every deal. By embedding financing into the sales process, Capchase helps vendors close more deals, increase contract value, and access their booked revenue immediately—without balance sheet risk or added debt. And doing so in an intuitive platform that matches the speed and needs of modern sales and finance teams. Since 2020, Capchase has powered over $2.5 billion in financing for thousands of high-growth companies worldwide, backed by leading fintech investors. We are redefining how B2B vendors accelerate revenue and manage working capital. Learn more: www.capchase.com Available in the U.S., Canada, U.K., Ireland, Spain, Finland, Belgium, Netherlands, and Sweden.
$26.0M Unknown
today
Solstice Health
Solstice Health was founded in 2012 as a Direct Primary Care & Wellness medical clinic offering cost-effective and transparent healthcare with excellence, for all patients. After 10 years of shifting the healthcare paradigm in Wisconsin, we have taken transparency and care to a whole new level. Solstice Health is the first and only clinic of its kind in the country with a strong DPC foundation, now offering Direct Surgical Care all under one umbrella. By continually eliminating insurance and middlemen at every level within it’s healthcare ecosystem, we are now offering best-in-class surgeries at rates 70-80% lower than any large hospital system. We include all costs from our board certified surgeons and anesthesiologists, along with facility fees in one low price bill with no hidden costs or surprises. From your first establishing primary care visit, to your pre-operative physical, surgery, and post-operative follow up, we can take care of all of your healthcare needs directly and transparently!
$21.0M Series a
today